Integrated Quantitative Investments’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
Integrated Quantitative Investments's NEO Position: Q3 2026 in Review
Integrated Quantitative Investments opened a new position in NeoGenomics (NEO) in Q3 2026: 132,356 shares worth $2.43M. The stake represents 0.42% of the portfolio and ranks #41 among its holdings.
296 funds tracked by Wall St. Rank hold NEO as of Q3 2026.
- Integrated Quantitative Investments held 132,356 shares of NeoGenomics worth $2.43M as of Q3 2026.
- NeoGenomics was a new Integrated Quantitative Investments position in Q3 2026.
- NeoGenomics made up 0.42% of Integrated Quantitative Investments's portfolio in Q3 2026, its #41 holding.
- 296 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2026.
Based on Integrated Quantitative Investments's 13F filing for Q3 2026, filed 13 Nov 2026.